|
|
|
Insider
Information: |
Duggan Robert W |
Relationship: |
Chief Executive Office... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
594,894,754 |
|
Indirect Shares
|
1,046,059 |
|
|
Direct
Value |
$5,079,682,600 |
|
|
Indirect Value
|
$10,153,978 |
|
|
Total
Shares |
595,940,813 |
|
|
Total
Value |
$5,089,836,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
0
|
Stock
price went up :
|
17
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
Percentage
Gain/Loss : |
33.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ISRG |
Intuitive Surgical Inc |
Director |
|
2011-05-03 |
4 |
S |
$354.46 |
$708,920 |
D/D |
(2,000) |
0 |
0 |
- |
|
ISRG |
Intuitive Surgical Inc |
Director |
|
2011-05-03 |
4 |
OE |
$47.09 |
$94,180 |
D/D |
2,000 |
2,000 |
0 |
- |
|
ISRG |
Intuitive Surgical Inc |
Director |
|
2011-05-18 |
4 |
OE |
$47.09 |
$47,090 |
D/D |
1,000 |
1,000 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman & CEO |
|
2011-06-21 |
4 |
B |
$8.85 |
$6,000,300 |
D/D |
678,000 |
12,081,244 |
3.23 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman and CEO |
|
2012-03-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(22,000) |
502,114 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman and CEO |
|
2013-12-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,000) |
371,119 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman and CEO |
|
2015-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
152,635 |
13,230,316 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman and CEO |
|
2015-03-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,785 |
13,225,531 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman and CEO |
|
2015-05-26 |
4 |
D |
$261.25 |
$2,147,483,647 |
D/D |
(13,225,531) |
0 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
Chairman and CEO |
|
2015-05-26 |
4 |
D |
$261.25 |
$95,553,494 |
I/I |
(365,755) |
0 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-02-09 |
4 |
B |
$11.64 |
$484,503 |
D/D |
41,624 |
2,173,359 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-03-16 |
4 |
B |
$22.54 |
$1,782,352 |
D/D |
73,782 |
2,247,141 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-03-17 |
4 |
B |
$24.07 |
$622,452 |
D/D |
25,859 |
2,273,000 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-03-18 |
4 |
B |
$23.01 |
$2,427,127 |
D/D |
105,486 |
2,378,486 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-06 |
4 |
B |
$18.54 |
$1,263,921 |
D/D |
65,400 |
2,452,886 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-07 |
4 |
B |
$19.59 |
$1,843,795 |
D/D |
94,100 |
2,546,986 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-10 |
4 |
B |
$20.38 |
$674,531 |
D/D |
31,964 |
2,578,950 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-17 |
4 |
B |
$23.15 |
$2,661,945 |
D/D |
107,300 |
2,686,250 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-18 |
4 |
B |
$25.06 |
$1,576,025 |
D/D |
61,819 |
2,748,069 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-19 |
4 |
B |
$22.24 |
$3,567,743 |
D/D |
150,123 |
2,898,192 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-25 |
4 |
B |
$24.94 |
$628,113 |
D/D |
25,187 |
2,923,379 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-26 |
4 |
B |
$24.47 |
$244,690 |
D/D |
10,000 |
2,933,379 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-27 |
4 |
B |
$22.95 |
$4,590 |
D/D |
200 |
2,933,579 |
2.37 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-28 |
4 |
B |
$23.85 |
$596,250 |
D/D |
25,000 |
2,958,579 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-28 |
4 |
B |
$24.00 |
$840,000 |
I/I |
35,000 |
35,000 |
1.5 |
- |
|
318 Records found
|
|
Page 8 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|